RECENT COMMENTS

Constantinos Zambirinis (Thyroid cancer management): As you mentioned above, differentiated thyroid cancer is followed after treatment with the thyroglob [...]   »Read more

Dr Lobna Sedky (Serigne Magueye Gueye): Within Africa,the scope of cancer differs even between various geographic regions. Being an oncologi [...]   »Read more

DR PUSHKAL DWIVEDI (World Cancer Declaration): I FULLY AGREE!   »Read more

Dr Olayinka O Adegbehingbe (World Cancer Declaration): Dear Prof Franco Cavalli, The World Cancer Declaration is great and impacts in developing countries [...]   »Read more

Tung Dinh Nguyen (World Cancer Declaration): Dear Dr F Cavalli, I have had a lot of chance to see Dr F. Cacalli In Hue, Vietnam. The World Ca [...]   »Read more

 

Article type: Editorial

Keywords: geriatric oncology, International Society of Geriatric Oncology, .

This article has 0 comments

Facebook Twitter Share - Send - Print - Pdf

 

Elderly patients deserve better

Elderly patients
deserve better

Two sets of statistics have recently been published which together have major implications for Europe’s cancer patients of the future. In February the International Agency for Research on Cancer revealed that the number of new cases in Europe rose by 10% between 2004 and 2006, from 2.9 million to 3.2 million. In March, a report published in the Annals of Oncology estimated that the rate of cancer mortality in Europe fell by 12.5% between 1987 and 2002, from 191 to 167 per 100,000 head of population

» Kathy Redmond

To read the complete article please click on the pdf icon

 
COMMENTS (0)
When submitted, your comment will be moderated. Messages which may be considered defamatory, which incite hatred or contain foul or abusive language, or are gratuitously offensive, will not be published. Please ensure that your comments are concise and relevant to the topic in question. Off-topic comments and comments without a username will not be published.

ESO reserves the absolute right not to publish comments.
  Name (required)
  E-mail (will not be published) (required)
  Captcha code (required)

CancerWorld invites you to visit:

 
CancerWorld is a pioneering initiative of the European School of Oncology financially supported through Sharing Progress in Cancer Care, a collaborative programme between ESO and Amgen, AstraZeneca, Eisai, Eli Lilly, GlaxoSmithKline, Merck and Novartis.